TMCNet:  Shares of Ligand Pharmaceuticals Rank the Lowest in Terms of Earnings Yield in the Biotechnology Industry (LGND, ONXX, CRIS, TRGT, GHDX)

[November 23, 2012]

Shares of Ligand Pharmaceuticals Rank the Lowest in Terms of Earnings Yield in the Biotechnology Industry (LGND, ONXX, CRIS, TRGT, GHDX)

Nov 23, 2012 (SmarTrend(R) News Watch via COMTEX) -- Below are the three companies in the Biotechnology industry with the lowest earnings yields. Earnings yield is useful to compare the relative benefit of owning a stock vs. owning other yield assets such as bonds. If the earnings yield is higher, stocks may be considered undervalued.Ligand Pharmaceuticals ranks lowest with a an earnings yield of 0.1%. Following is Onyx Pharmaceuticals with a an earnings yield of 0.2%. Curis ranks third lowest with a an earnings yield of 0.9%.


Targacept follows with a an earnings yield of 0.9%, and Genomic Health rounds out the bottom five with a an earnings yield of 1.0%.

SmarTrend recommended that its subscribers protect gains by selling shares of Genomic Health on October 23rd, 2012 by issuing a Downtrend alert when the shares were trading at $31.80. Since that call, shares of Genomic Health have fallen 12.0%. We are now looking for when a new Uptrend will commence and will alert SmarTrend subscribers in real time.

Write to Chip Brian at cbrian@mysmartrend.com --------------------------------------------------------------------------------------------- SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup

[ Back To Cloud Computing 's Homepage ]